Xincheng Li
-
- Cancer, Lipids, and Metabolism 3
- MicroRNA in disease regulation 2
-
- RNA modifications and cancer 5
-
- Ferroptosis and cancer prognosis 4
- Pulmonary Hypertension Research and Treatments 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- Pancreatic and Hepatic Oncology Research 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xincheng Li
30 papers receiving 387 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Cancer Research 158
- Molecular Biology 243
- Fluid Flow and Transfer Processes 17
- Pulmonary and Respiratory Medicine 83
- Nephrology 15
Countries citing papers authored by Xincheng Li
This map shows the geographic impact of Xincheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xincheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xincheng Li more than expected).
Fields of papers citing papers by Xincheng Li
This network shows the impact of papers produced by Xincheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xincheng Li. The network helps show where Xincheng Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xincheng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 20 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 7 | |
| 4 | LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growthbreakdown → | 2024 | 60 |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 7 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 26 | |
| 12 | 2023 | 6 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 14 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2022 | 28 | |
| 19 | 2022 | 5 | |
| 20 | 2022 | 2 |
About Xincheng Li
Xincheng Li is a scholar working on Internal Medicine, Cancer Research and Hepatology, having authored 34 papers that have together received 391 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Pulmonary Hypertension Research and Treatments (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer, Lipids, and Metabolism (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (158 citations), Molecular Biology (243 citations) and Fluid Flow and Transfer Processes (17 citations). Xincheng Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Ruyuan Yu, Miaoling Tang, Shuxia Zhang, Jun Li, Xinyi Liao, Libing Song, Yameng Hu, Meisongzhu Yang, Suwen Chen and Ziwen Li. Their work appears in journals such as Nucleic Acids Research, Nature Cell Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.